199 related articles for article (PubMed ID: 18999931)
1. Gene therapy for human nasopharyngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model.
Ren SP; Wang L; Wang H; Wu B; Han Y; Wang LS; Wu CT
Cancer Biother Radiopharm; 2008 Oct; 23(5):591-602. PubMed ID: 18999931
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells.
Pan D; Wei X; Liu M; Feng S; Tian X; Feng X; Zhang X
Neurol Res; 2010 Jun; 32(5):502-9. PubMed ID: 19589203
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.
Parney IF; Petruk KC; Zhang C; Farr-Jones M; Sykes DB; Chang LJ
Hum Gene Ther; 1997 Jun; 8(9):1073-85. PubMed ID: 9189765
[TBL] [Abstract][Full Text] [Related]
4. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
5. Genetically modified myeloma cell vaccine inducing antitumor immune response in vivo.
Ren SP; Wang LS; Guo Q; Wang H; Jia XX; Xu J; Wang HX; Wu CT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):54-60. PubMed ID: 16584592
[TBL] [Abstract][Full Text] [Related]
6. Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immunogenicity in laryngeal cancer cells.
Qiu Z; Lao M; Wu C
Cancer Lett; 2001 Jun; 167(1):25-32. PubMed ID: 11323095
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro.
Ren SP; Wu CT; Huang WR; Lu ZZ; Jia XX; Wang L; Lao MF; Wang LS
Cancer Immunol Immunother; 2006 Apr; 55(4):375-85. PubMed ID: 16001164
[TBL] [Abstract][Full Text] [Related]
8. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
9. [Adenovirus-mediated transfer of human wild-type p53, GM-CSF, and B7-1 genes efficiently produces growth suppression and apoptosis of hepatocellular cells in vitro].
Shi M; Wang F; Liu M; Zhang B; Qiu Z; Lei Z; Masayoshi N; Gao L; Wu Z
Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):229-31. PubMed ID: 11602056
[TBL] [Abstract][Full Text] [Related]
10. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
11. Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.
Feng S; Han S; Pan D; Liu M; Feng X; Dong T; Li W; Wei X
Tumour Biol; 2014 May; 35(5):4411-7. PubMed ID: 24408016
[TBL] [Abstract][Full Text] [Related]
12. Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes.
Qiu ZH; Wu CT; Lao MF; Pan LZ; Li YM
Cancer Lett; 2002 Aug; 182(2):147-54. PubMed ID: 12048160
[TBL] [Abstract][Full Text] [Related]
13. Experimental studies on the inhibition of adenovirus-ING4-OSM therapy on nasopharyngeal carcinoma proliferation in vitro and in vivo.
Han Z; Zhou C; Sun B; Yan Q; Zhang J
Cell Biochem Biophys; 2014 Dec; 70(3):1573-8. PubMed ID: 25005773
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
Wang L; Qi X; Sun Y; Liang L; Ju D
Cancer Gene Ther; 2002 Oct; 9(10):819-24. PubMed ID: 12224022
[TBL] [Abstract][Full Text] [Related]
16. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
[TBL] [Abstract][Full Text] [Related]
17. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Janousková O; Síma P; Kunke D
Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2.
Kudo-Saito C; Wansley EK; Gruys ME; Wiltrout R; Schlom J; Hodge JW
Clin Cancer Res; 2007 Mar; 13(6):1936-46. PubMed ID: 17363550
[TBL] [Abstract][Full Text] [Related]
19. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
Choi KJ; Zhang SN; Choi IK; Kim JS; Yun CO
Gene Ther; 2012 Jul; 19(7):711-23. PubMed ID: 21993173
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
Day KV; Li D; Liu S; Guo M; O'Malley BW
Laryngoscope; 2001 May; 111(5):801-6. PubMed ID: 11368071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
